Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-24

FDA Approved: BAQSIMI — Original Application (Amphastar Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved BAQSIMI (glucagon) from Amphastar Pharmaceuticals in an Original Application for the treatment of severe hypoglycemia in people with diabetes melli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BAQSIMI (Glucagon)

Snippet

ORIG AP for BAQSIMI (GLUCAGON)